Navigation Links
Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis
Date:6/13/2008

Paris, France, Friday 13 June 2008: Infections during the first year of life are a marker of increased risk of developing specific types of arthritis later in life, according to new research from Sweden presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. Researchers from the Karolinska Institute in Sweden found that infants who were hospitalised for infection before their first birthday had an increased likelihood of developing either juvenile idiopathic arthritis (JIA) or adult rheumatoid arthritis (RA) in later life.

Investigator Dr Cecilia Carlens of The Karolinska University Hospital, Stockholm, Sweden, said: "Whilst recent research has suggested that early life infections are of importance to the maturation of the immune system in general, our analysis shows a link between perinatal infection and increased RA and JIA risk in particular, highlighting the importance of a child's formative months on his or her rheumatic health in later life."

The Swedish register-based case-control study reviewed recorded data on individuals born nationwide between 1973 and 2002, and involved 333 RA patients and 3,334 JIA patients. The analysis revealed that an increase in infections within the first 12 months is associated with an increased risk of developing JIA (odds ratio =1.9, 95% confidence interval 1.7-2.1) and sero-negative RA (odds ratio =2.6, 95% confidence interval 1.0-7.0), a distinct type of RA that is less aggressive than sero-positive RA.

However, other parts of the study suggested that perinatal charactertics, such as low birth weight (odds ratio =0.7, 95% confidence interval 0.5-1.0) and the duration of the gestational period may also affect arthritis risk in later life. A longer gestational period of over 42 weeks, emerged as a potential risk factor for developing JIA (odds ratio =1.5, 95% confidence interval 1.2-2.0).

The patient data reviewed was taken from the Swedish Inpatient Register and the Early Arthritis Register. Using the Swedish Medical Birth Register, four controls were randomly selected per case, matched by sex, year, and delivery-unit. Linkage to the Medical Birth Register and the Swedish Inpatient Register provided the necessary information on maternal-, pregnancy- and birth-characteristics, and infections during first year of life. Univariate odds ratios (OR) were calculated using conditional logistic regression.


'/>"/>

Contact: Rory Berrie / Camilla Dormer
eularpressoffice@uk.cohnwolfe.com
44-077-892-70392
European League Against Rheumatism
Source:Eurekalert

Related medicine news :

1. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
2. Spotting Vitamin-D Deficiency in the Absence of Symptoms: ZRT Laboratorys New, One-of-a-Kind Blood Spot Test Answers the Call for Early Detection of Rapidly Rising D-Deficiencies
3. JCI online early table of contents: June 12, 2008
4. Canary Foundation and American Cancer Society Award Five Postdoctoral Fellowships in Early Cancer Detection
5. 19th Annual Susan G. Komen National Race for the Cure(R) Draws Nearly 50,000 Participants, Celebrities; Brings Record Funds to National Capital Area
6. JCI online early table of contents: June 5, 2008
7. Nearly 1 in 5 teenagers admit eating problems, but anxiety is a bigger problem than appearance
8. Being Born Small, Early Raises Autism Risk
9. Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer
10. Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer
11. Paclitaxel Plus Chemo Improves Outcomes in Early Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: